25 February 2020

The Blue Diamond Gallery

In line with the NFU initiative “Broad Consent at the Gate” (Breed Consent aan de Poort), the Radboud Biobank is currently conducting a feasibility study examining consent procedures for the use of residual material for scientific research. Residual material encompasses biomaterials leftover from standard clinical procedures, clinical imaging and medical data. The specific aim of this study is to evaluate the impact of implementing an active consent procedure (i.e. opt-in consent, which requires explicit consent) in place of the passive consent procedure currently used in the Radboudumc (i.e. opt-out consent, which requires explicit objection). Importantly, this study does not override the consent status of previously established research studies.
As of January 13, 2020, each new patient registering for the first time at the Radboudumc is actively asked for consent to use his/her residual biomaterial, clinical imaging and medical data for scientific research. To date, there has been no major organizational obstacles in the implementation of this new consent procedure. However, its impact on available material and data is still under evaluation. In addition to quantitative analyses, qualitative research exploring underlying motivations of patients who consent or do not consent to the use of their material and data will also be performed. This feasibility study will be further expanded to assess the impact of the new consent procedure on vulnerable patient groups, i.e. children (<16 years old), acute care patients, and incapacitated patients.   
For further information, please visit our website, “Use of medical data and leftover biomaterial”  (available in Dutch only), or contact Dr. Jennifer Lutomski, project leader, at Jennifer.Lutomski@radboudumc.nl.
 
  • Want to know more about these subjects? Click on the buttons below for more news.

    Radboud biobank

Related news items


Process and time constraints for external sample issuance

6 May 2025

Prior to issuing samples intended for an external applicant, the Radboud Biobank first draws up a quotation of the expected costs. This process will lead to some delays in distribution.

read more

Periodic invoicing biobank collections

6 May 2025

As of this year, the Radboud Biobank will periodically charge biobank collections for the processing and storage costs incurred.

read more

National Biobanks & Collections Dag 2025

6 May 2025

The second edition of the National Biobanks & Collections Day took place on March 27, 2025, in Nijmegen and attracted 150 participants from all over the Netherlands.

read more

Radboud Biobank Office Relocation

30 January 2025

We would like to inform you about the upcoming relocation of the Radboud Biobank office.

read more

Request for DNA samples from stored whole blood and/or saliva

30 January 2025

There are biobank collections that collected whole blood and saliva before joining the Radboud Biobank to isolate DNA from them later.

read more

Great news!

30 January 2025

We have good news for both new and existing collections and projects interested in isolating PBMCs (Peripheral Blood Mononuclear Cells)!

read more